Managing Antiplatelet Therapy in Patients with Acute Coronary Syndrome

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this podcast, Toby Trujillo, PharmD, BCPS, an associate professor at the University of Colorado Denver School of Pharmacy, discusses issues related to options for managing antiplatelet therapy in patients with acute coronary syndrome. To listen to the podcast, click here.
Related Articles
A Merck study found patients who received a cholesterol-lowering combination of ezetimibe/simvastatin experienced fewer major cardiovascular events than those taking simvastatin alone.
A new study presented today at American Heart Association’s Scientific Sessions suggests clinicians may have more evidenced-based options when considering preventative therapy for high-risk acute coronary syndrome patients.
Adding another type of cholesterol-lowering drug to statin therapy can better prevent heart attacks and strokes in high-risk patients with acute coronary syndrome.
Many cardiologists and pharmacists are concerned about clopidogrel, especially when it is prescribed for patients with diabetes.
Latest Issues
$auto_registration$